(VLTO) Veralto - Overview
Stock: Water Analytics, Water Treatment, Marking Coding, Color
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.45% |
| Yield on Cost 5y | 0.58% |
| Yield CAGR 5y | 21.05% |
| Payout Consistency | 100.0% |
| Payout Ratio | 11.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 25.6% |
| Relative Tail Risk | -3.27% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.44 |
| Alpha | -16.83 |
| Character TTM | |
|---|---|
| Beta | 0.667 |
| Beta Downside | 0.626 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.73% |
| CAGR/Max DD | 0.22 |
Description: VLTO Veralto December 17, 2025
Veralto Corporation (NYSE:VLTO) delivers water-focused analytics and treatment solutions alongside marking, coding, and packaging-color technologies. It operates through two distinct segments: Water Quality (WQ), which sells precision instruments, chemical reagents, digital services and treatment systems under brands such as Hach, Trojan Technologies, and ChemTreat; and Product Quality & Innovation (PQI), which offers marking/coding hardware, software for digital asset and product information management, inline printing, design software, and color-management services via Videojet, Linx, Esko, X-Rite, and Pantone.
Key market signals that could influence Veralto’s outlook include: (1) the global water-analytics market is projected to grow at a ~6% CAGR through 2030, driven by tightening regulations and rising water-scarcity concerns; (2) Veralto reported FY-2023 revenue of roughly $1.1 billion, with the WQ segment contributing about 68% and posting a 5% YoY growth despite a modest slowdown in industrial capital-expenditure; and (3) ESG-linked procurement is accelerating demand for traceable, low-impact packaging, a trend that directly benefits the PQI segment’s color-management and digital asset solutions.
For a deeper, data-driven assessment of VLTO’s valuation dynamics, you might explore the analytics platform ValueRay, which aggregates real-time financial metrics and peer benchmarks.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 940.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 0.38 > 1.0 |
| NWC/Revenue: 25.00% < 20% (prev 21.99%; Δ 3.01% < -1%) |
| CFO/TA 0.14 > 3% & CFO 1.08b > Net Income 940.0m |
| Net Debt (642.0m) to EBITDA (1.35b): 0.48 < 3 |
| Current Ratio: 1.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (250.5m) vs 12m ago 0.08% < -2% |
| Gross Margin: 59.95% > 18% (prev 0.60%; Δ 5935 % > 0.5%) |
| Asset Turnover: 78.06% > 50% (prev 81.06%; Δ -3.00% > 0%) |
| Interest Coverage Ratio: 13.22 > 6 (EBITDA TTM 1.35b / Interest Expense TTM 96.0m) |
Altman Z'' 3.74
| A: 0.18 (Total Current Assets 3.43b - Total Current Liabilities 2.06b) / Total Assets 7.69b |
| B: 0.20 (Retained Earnings 1.52b / Total Assets 7.69b) |
| C: 0.18 (EBIT TTM 1.27b / Avg Total Assets 7.05b) |
| D: 0.68 (Book Value of Equity 3.11b / Total Liabilities 4.59b) |
| Altman-Z'' Score: 3.74 = AA |
Beneish M -3.04
| DSRI: 1.04 (Receivables 897.0m/812.0m, Revenue 5.50b/5.19b) |
| GMI: 0.99 (GM 59.95% / 59.60%) |
| AQI: 0.88 (AQ_t 0.52 / AQ_t-1 0.59) |
| SGI: 1.06 (Revenue 5.50b / 5.19b) |
| TATA: -0.02 (NI 940.0m - CFO 1.08b) / TA 7.69b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of VLTO shares?
Over the past week, the price has changed by -10.75%, over one month by -10.98%, over three months by -7.71% and over the past year by -8.81%.
Is VLTO a buy, sell or hold?
- StrongBuy: 6
- Buy: 3
- Hold: 9
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the VLTO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 110.6 | 22.1% |
| Analysts Target Price | 110.6 | 22.1% |
| ValueRay Target Price | 91.6 | 1.1% |
VLTO Fundamental Data Overview February 08, 2026
P/E Forward = 21.645
P/S = 4.0866
P/B = 7.2403
P/EG = 3.375
Revenue TTM = 5.50b USD
EBIT TTM = 1.27b USD
EBITDA TTM = 1.35b USD
Long Term Debt = 1.97b USD (from longTermDebt, two quarters ago)
Short Term Debt = 700.0m USD (from shortTermDebt, last quarter)
Debt = 2.67b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 642.0m USD (from netDebt column, last quarter)
Enterprise Value = 23.13b USD (22.49b + Debt 2.67b - CCE 2.03b)
Interest Coverage Ratio = 13.22 (Ebit TTM 1.27b / Interest Expense TTM 96.0m)
EV/FCF = 22.81x (Enterprise Value 23.13b / FCF TTM 1.01b)
FCF Yield = 4.38% (FCF TTM 1.01b / Enterprise Value 23.13b)
FCF Margin = 18.43% (FCF TTM 1.01b / Revenue TTM 5.50b)
Net Margin = 17.08% (Net Income TTM 940.0m / Revenue TTM 5.50b)
Gross Margin = 59.95% ((Revenue TTM 5.50b - Cost of Revenue TTM 2.20b) / Revenue TTM)
Gross Margin QoQ = 59.31% (prev 60.11%)
Tobins Q-Ratio = 3.01 (Enterprise Value 23.13b / Total Assets 7.69b)
Interest Expense / Debt = 0.75% (Interest Expense 20.0m / Debt 2.67b)
Taxrate = 13.31% (39.0m / 293.0m)
NOPAT = 1.10b (EBIT 1.27b * (1 - 13.31%))
Current Ratio = 1.67 (Total Current Assets 3.43b / Total Current Liabilities 2.06b)
Debt / Equity = 0.86 (Debt 2.67b / totalStockholderEquity, last quarter 3.11b)
Debt / EBITDA = 0.48 (Net Debt 642.0m / EBITDA 1.35b)
Debt / FCF = 0.63 (Net Debt 642.0m / FCF TTM 1.01b)
Total Stockholder Equity = 2.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.33% (Net Income 940.0m / Total Assets 7.69b)
RoE = 34.47% (Net Income TTM 940.0m / Total Stockholder Equity 2.73b)
RoCE = 27.01% (EBIT 1.27b / Capital Employed (Equity 2.73b + L.T.Debt 1.97b))
RoIC = 20.92% (NOPAT 1.10b / Invested Capital 5.26b)
WACC = 7.55% (E(22.49b)/V(25.16b) * Re(8.37%) + D(2.67b)/V(25.16b) * Rd(0.75%) * (1-Tc(0.13)))
Discount Rate = 8.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.81%
[DCF Debug] Terminal Value 79.80% ; FCFF base≈936.4m ; Y1≈937.2m ; Y5≈994.2m
Fair Price DCF = 74.58 (EV 19.16b - Net Debt 642.0m = Equity 18.52b / Shares 248.3m; r=7.55% [WACC]; 5y FCF grow -0.46% → 2.90% )
EPS Correlation: 92.25 | EPS CAGR: 11.63% | SUE: 3.65 | # QB: 2
Revenue Correlation: 95.11 | Revenue CAGR: 4.77% | SUE: -0.48 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.00 | Chg30d=-0.012 | Revisions Net=+0 | Analysts=14
EPS current Year (2026-12-31): EPS=4.19 | Chg30d=+0.017 | Revisions Net=+2 | Growth EPS=+7.3% | Growth Revenue=+6.3%
EPS next Year (2027-12-31): EPS=4.55 | Chg30d=+0.020 | Revisions Net=+2 | Growth EPS=+8.8% | Growth Revenue=+5.4%